A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.


Updates from The Motley Fool

Latest updates on Merck and Co. from Fool.com.


Stock Performance

MRK vs. S&P 500 | 2 Year Performance
View Interactive MRK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Merck and Co..
Current Price: $58.82
Prev Close: $58.79
Open: $58.99
Bid: $58.55
Ask: $59.24
Day's Range: $58.55 - $59.08
52wk Range: $45.69 - $60.07
Volume: 6,263,634
Avg Vol 9,813,354
Market Cap: $164.32B
P/E (ttm): 36.07
EPS (ttm): $1.63
Div & Yield: $1.84 (3.1%)

Company Rating

What our community thinks about Merck and Co..
CAPS Rating 4 out of 5
 
2725 Outperform
217 Underperform
CAPS All Stars
 
693 Outperform
35 Underperform

How do you think Merck and Co. will perform against the market?



You pick for Merck and Co. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kenneth C. Frazier, CEO

69% Approve

Based on 673 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Merck and Co..

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers